The Development of New Interventional Clinical Trials on Obstructive Sleep Apnoea: Targeting the Outcome, Endotype and Trial Design

M Sánchez-de-la-Torre… - Archivos de …, 2023 - pubmed.ncbi.nlm.nih.gov
The Development of New Interventional Clinical Trials on Obstructive Sleep Apnoea: Targeting
the Outcome, Endotype and Trial Design The Development of New Interventional Clinical …

A critical review of the treatment options available for obstructive sleep apnoea: an overview of the current literature available on treatment methods for obstructive …

AJ Booth, Y Djavadkhani, NS Marshall - Bioscience Horizons, 2014 - academic.oup.com
Obstructive sleep apnoea (OSA) is a leading yet often undiagnosed cause of daytime
sleepiness. It affects between 3 and 7% of the adult population, and the prevalence is …

Current and novel treatment options for obstructive sleep apnoea

W Randerath, J de Lange, J Hedner… - ERJ open …, 2022 - Eur Respiratory Soc
Obstructive sleep apnoea is a challenging medical problem due to its prevalence, its impact
on quality of life and performance in school and professionally, the implications for risk of …

[HTML][HTML] Patients' preference of established and emerging treatment options for obstructive sleep apnoea

T Campbell, MF Pengo, J Steier - Journal of thoracic disease, 2015 - ncbi.nlm.nih.gov
Background Obstructive sleep apnoea (OSA) is the most common form of sleep-disordered
breathing. The standard treatment, continuous positive airway pressure (CPAP), has limited …

[HTML][HTML] Beyond usual care: a multidisciplinary approach towards the treatment of obstructive sleep apnoea

MA Arachchige, J Steier - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Obstructive Sleep Apnoea (OSA) is common and characterised by repeated apnoeas and
hypopnoeas while asleep due to collapse of the upper airway. OSA can have a significant …

[HTML][HTML] European Respiratory Society guideline on non-CPAP therapies for obstructive sleep apnoea

W Randerath, J Verbraecken… - European …, 2021 - Eur Respiratory Soc
Treatment of obstructive sleep apnoea (OSA) in adults is evolving, as new therapies have
been explored and introduced in clinical practice, while other approaches have been refined …

Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions

M Kohler, JR Stradling - Expert opinion on investigational drugs, 2011 - Taylor & Francis
The standard treatment for obstructive sleep apnoea (OSA) is continuous positive airway
pressure (CPAP). Depending on selection criteria and quality of care, up to 50% of patients …

Recent developments in the treatment of obstructive sleep apnea

T Verse, W Pirsig, BA Stuck, K Hörmann… - American Journal of …, 2003 - Springer
Modern sleep medicine has been in existence for only 20 years and therefore has to be
regarded as a comparatively recent field of specialization. For this reason it is not surprising …

Is it time to redefine obstructive sleep apnoea?

S Sakhamuri, S Teelucksingh… - Respirology, 2020 - search.ebscohost.com
Keywords: apnoea-hypopnoea index; obstructive sleep apnoea; upper limit of normal EN
apnoea-hypopnoea index obstructive sleep apnoea upper limit of normal 802 803 2 …

Drug treatments for obstructive sleep apnoea.

I Smith, T Lasserson, J Wright - The Cochrane Database of …, 2002 - europepmc.org
Background The treatment of choice for moderate to severe obstructive sleep apnoea (OSA)
is continuous positive airway pressure (CPAP) via a mask during sleep. However this is not …